News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Azamian Bobak R.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/25/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 8,000 shares
@ $17.23, valued at
$137.8k
|
|
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 9,000 shares
@ $18.58, valued at
$167.2k
|
|
| 06/12/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 3,100 shares
@ $20.01, valued at
$62k
|
|
| 05/19/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 8,000 shares
@ $15.9, valued at
$127.2k
|
|
| 05/12/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 9,000 shares
@ $16.8, valued at
$151.2k
|
|
| 05/02/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 4,278 shares
@ $15.13, valued at
$64.7k
Sold 5,841 shares
@ $15.1, valued at
$88.2k
|
|
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 679 shares
@ $12.89, valued at
$8.8k
Sold 709 shares
@ $12.64, valued at
$9k
Sold 737 shares
@ $12.15, valued at
$9k
|
|
| 03/21/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 795 shares
@ $13.28, valued at
$10.6k
Sold 741 shares
@ $12.61, valued at
$9.3k
|
|
| 03/17/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 8,000 shares
@ $13.79, valued at
$110.3k
Sold 791 shares
@ $13.43, valued at
$10.6k
Exercised 11,299 restricted stock units
@ $0 |
|
| 03/10/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Granted 100,242 options to buy
@ $15, valued at
$1.5M
Granted 67,900 restricted stock units
@ $0 |
|
| 03/10/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 4,853 shares
@ $15.02, valued at
$72.9k
Sold 717 shares
@ $15.01, valued at
$10.8k
|
|
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 4,856 shares
@ $15.45, valued at
$75k
|
|
| 01/24/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 411 shares
@ $15, valued at
$6.2k
|
|
| 01/20/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 8,000 shares
@ $14.56, valued at
$116.5k
Sold 240 shares
@ $15, valued at
$3.6k
|
|
| 01/13/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 3,904 shares
@ $15.11, valued at
$59k
|
|
| 01/11/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 729 shares
@ $15.15, valued at
$11k
Sold 905 shares
@ $15.17, valued at
$13.7k
|
|
| 12/20/2022 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 535 shares
@ $15.01, valued at
$8k
|
|
| 12/16/2022 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 6,420 shares
@ $15.08, valued at
$96.8k
|
|
| 11/18/2022 |
4
| Azamian Bobak R. (President and CEO) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 7,255 shares
@ $16.81, valued at
$122k
Sold 745 shares
@ $17.31, valued at
$12.9k
|
|
| 10/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/14/2022 |
4
| Azamian Bobak R. (President and CEO) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 6,179 shares
@ $15.76, valued at
$97.4k
Sold 2,821 shares
@ $16.24, valued at
$45.8k
|
|
| 09/23/2022 |
4
| Azamian Bobak R. (President and CEO) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 7,900 shares
@ $16.3, valued at
$128.8k
Sold 100 shares
@ $17.045, valued at
$1.7k
|
|
| 09/16/2022 |
4
| Azamian Bobak R. (President and CEO) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 9,000 shares
@ $16.01, valued at
$144.1k
|
|
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| Azamian Bobak R. (President and CEO) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 5,033 shares
@ $27.76, valued at
$139.7k
Sold 800 shares
@ $28.21, valued at
$22.6k
|
|
| 10/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|